Fig. 3From: Smokeless consumption of medical cannabis pharmacokinetics, safety and feasibility of the CannaHALER© a phase 1a studyPlasma Cmax levels per mg of ∆9-THC administered by intravenous, inhaler, vaporization and smoking. The CannaHaler yielded the highest increase of THC Cmax even when compared with the recently published data of the Syqe Inhaler, the Volcano vaporizer and common smokingBack to article page